Stomach Cancer Research
Pembrolizumab Secures FDA Approval in Stomach CancerPosted: October 12, 2017
The FDA has granted accelerated approval to the immunotherapy drug pembrolizumab (Keytruda®) for use in patients with advanced gastric (stomach) cancer that is PD-L1 positive.
TCGA researchers identify four subtypes of stomach cancerPosted: July 23, 2014
Stomach cancers fall into four distinct molecular subtypes, researchers with The Cancer Genome Atlas (TCGA) Network have found. Scientists report that this discovery could change how researchers think about developing treatments for stomach cancer, also called gastric cancers or gastric adenocarcinomas.
Chemotherapy Before Surgery May Increase Survival in Stomach CancerUpdated: October 19, 2011
Chemotherapy given before surgery for cancer of the lower esophagus and stomach increased the number of patients surviving for five years compared to surgery alone, according to findings presented at the 2007 ASCO meeting in Chicago.